Table 4.
Patient profiles and reproductive outcomes of patients undergoing euploid embryo transfer after standard progesterone protocol vs. patients undergoing euploid embryo transfer after pET
| Euploid standard ET | Euploid pET | p value | |
|---|---|---|---|
| Patients | 26 | 17 | 1.0 |
| RIF | 18 (69.2) | 12 (68.4) | |
| 1 prior failed | 8 (30.8) | 5 (31.6) | |
| Age | 36.8 ± 4.1 years | 37.6 ± 3.9 years | 0.33 |
| Prior implantation failures | 2.2 ± 1.4 times | 2.1 ± 0.9 times | 0.79 |
| After all biopsies, receptive on | – | ||
| P + 4 | 0 (0) | 0 (0) | |
| P + 5 | 26 (100) | 0 (0) | |
| P + 6 | 0 (0) | 14 (82.3) | |
| P + 7 | 0 (0) | 3 (17.6) | |
| Time from biopsy to next cycle | 97.3 ± 51.9 days | 61.3 ± 48.2 days | 0.04 |
| Embryos transferred | 1.09 ± 0.3 embryos | 1 ± 0 embryos | 0.68 |
| Implantation rate | 14/26 (53.8) | 13/17 (76.5) | 0.13 |
| Ongoing pregnancy rate | 11/26 (42.3) | 11/17 (64.7) | 0.15 |
| Live birth ratea | 4/11 (36.3) | 4/11 (36.3) | 1.0 |
N.B. Values expressed as N (%). p < 0.05 is significant
ET embryo transfer, pET personalized embryo transfer, RIF recurrent implantation failure
aNot all ongoing pregnancies could be followed through to term; hence, live birth rates would not reflect true birth outcomes